Skip to main content
Top
Published in: Supportive Care in Cancer 11/2006

01-11-2006 | Original Article

Assessing cognitive function in cancer patients

Authors: Janette Vardy, Karen Wong, Qi-long Yi, Alison Park, Paul Maruff, Lynne Wagner, Ian F. Tannock

Published in: Supportive Care in Cancer | Issue 11/2006

Login to get access

Abstract

Goals of work

Some patients with cancer suffer cognitive impairment after chemotherapy. A brief, sensitive instrument is required to screen patients for cognitive impairment. In this study, we compare three possible screening instruments.

Materials and methods

Cancer patients (n=31) who had received adjuvant chemotherapy within 2 years underwent cognitive evaluation on three occasions. Fluent English speakers (n=20) completed the High Sensitivity Cognitive Screen (HSCS), the computer-based Headminder and CogHealth, and the Functional Assessment of Cancer Therapy-cognitive function (FACT-COG) questionnaire. Patients not fluent in English (NESB) (n=11) performed CogHealth and Headminder.

Results

The patients were aged 31–65 years, and 94% were women with breast cancer. At baseline, 6 of 20 (30%) had moderate–severe cognitive impairment on HSCS, 17 of 31 (55%) had scores greater than one standard deviation (SD) below the mean for normative data in one to two of three domains on Headminder, and on CogHealth, 8 of 31 (26%) were greater than one SD below the mean in at least two of six domains. A large practice effect was seen for the HSCS, with moderate–severe cognitive impairment decreasing from 30 to 5% between the first and second assessment. On FACT-COG, 9 of 19 patients (47%) rated their cognition as greater than one SD below that of a pre-chemotherapy breast cancer control group, with impact on quality of life greater than one SD below for 10 of 19 (53%) patients. No correlation was seen between objective cognitive testing and the FACT-COG.

Conclusions

CogHealth and Headminder were suitable for NESB patients. The HSCS is not recommended for longitudinal studies with short intervals between testing due to practice effect. There is poor correlation between the patients’ perception of their cognitive impairment and the objective tests.
Literature
1.
go back to reference van Dam FS, Schagen SB, Muller MJ, Boogerd W, vd Wall E, Droogleever Fortuy, ME, Rodenhuis S (1998) Impairment of cognitive function in women receiving adjuvant treatment for high-risk breast cancer: high-dose versus standard-dose chemotherapy. J Natl Cancer Inst 90:210–218CrossRefPubMed van Dam FS, Schagen SB, Muller MJ, Boogerd W, vd Wall E, Droogleever Fortuy, ME, Rodenhuis S (1998) Impairment of cognitive function in women receiving adjuvant treatment for high-risk breast cancer: high-dose versus standard-dose chemotherapy. J Natl Cancer Inst 90:210–218CrossRefPubMed
2.
go back to reference Wieneke MH, Dienst DE (1995) Neuropsychological assessment of cognitive functioning following chemotherapy for breast cancer. Psychooncology 4:61–66 Wieneke MH, Dienst DE (1995) Neuropsychological assessment of cognitive functioning following chemotherapy for breast cancer. Psychooncology 4:61–66
3.
go back to reference Schagen SB, van Dam FS, Muller MJ, Boogerd W, Lindeboom J, Bruning PF (1999) Cognitive deficits after postoperative adjuvant chemotherapy for breast carcinoma. Cancer 85:640–650CrossRefPubMed Schagen SB, van Dam FS, Muller MJ, Boogerd W, Lindeboom J, Bruning PF (1999) Cognitive deficits after postoperative adjuvant chemotherapy for breast carcinoma. Cancer 85:640–650CrossRefPubMed
4.
go back to reference Brezden CB, Phillips KA, Abdolell M, Bunston T, Tannock IF (2000) Cognitive function in breast cancer patients receiving adjuvant chemotherapy. J Clin Oncol 18:2695–2701PubMed Brezden CB, Phillips KA, Abdolell M, Bunston T, Tannock IF (2000) Cognitive function in breast cancer patients receiving adjuvant chemotherapy. J Clin Oncol 18:2695–2701PubMed
5.
go back to reference Ahles TA, Saykin AJ, Furstenberg CT, Cole B, Mott LA, Skalla K, Whedon MB, Bivens S, Mitchell T, Greenberg ER, Silberfarb PM (2002) Neuropsychologic impact of standard-dose systemic chemotherapy in long-term survivors of breast cancer and lymphoma. J Clin Oncol 20:485–493CrossRefPubMed Ahles TA, Saykin AJ, Furstenberg CT, Cole B, Mott LA, Skalla K, Whedon MB, Bivens S, Mitchell T, Greenberg ER, Silberfarb PM (2002) Neuropsychologic impact of standard-dose systemic chemotherapy in long-term survivors of breast cancer and lymphoma. J Clin Oncol 20:485–493CrossRefPubMed
6.
go back to reference Tchen N, Juffs HG, Downie FP, Yi QL, Hu H, Chemerynsky I, Clemons M, Crump M, Goss PE, Warr D, Tweedale ME, Tannock IF (2003) Cognitive function, fatigue, and menopausal symptoms in women receiving adjuvant chemotherapy for breast cancer. J Clin Oncol 21:4175–4183CrossRefPubMed Tchen N, Juffs HG, Downie FP, Yi QL, Hu H, Chemerynsky I, Clemons M, Crump M, Goss PE, Warr D, Tweedale ME, Tannock IF (2003) Cognitive function, fatigue, and menopausal symptoms in women receiving adjuvant chemotherapy for breast cancer. J Clin Oncol 21:4175–4183CrossRefPubMed
7.
go back to reference Phillips KA, Bernhard J (2003) Adjuvant breast cancer treatment and cognitive function: current knowledge and research directions. J Natl Cancer Inst 95:190–197PubMedCrossRef Phillips KA, Bernhard J (2003) Adjuvant breast cancer treatment and cognitive function: current knowledge and research directions. J Natl Cancer Inst 95:190–197PubMedCrossRef
8.
go back to reference Tannock IF, Ahles TA, Ganz PA, van Dam FS (2004) Cognitive impairment associated with chemotherapy for cancer: report of a workshop. J Clin Oncol 22:2233–2239CrossRefPubMed Tannock IF, Ahles TA, Ganz PA, van Dam FS (2004) Cognitive impairment associated with chemotherapy for cancer: report of a workshop. J Clin Oncol 22:2233–2239CrossRefPubMed
9.
go back to reference Bornstein R (1994) Methodological and conceptual issues in the study of cognitive change in HIV infection. In: Grant I, Martin A (eds) Neuropsychology of HIV Infection. Oxford Univ. Press, New York, pp 146–160 Bornstein R (1994) Methodological and conceptual issues in the study of cognitive change in HIV infection. In: Grant I, Martin A (eds) Neuropsychology of HIV Infection. Oxford Univ. Press, New York, pp 146–160
10.
go back to reference Butters N, Grant I, Haxby J, Judd LL, Martin A, McClelland J, Pequegnat W, Schacter D, Stover E (1990) Assessment of AIDS-related cognitive changes: recommendations of the NIMH workshop on neuropsychological assessment approaches. J Clin Exp Neuropsychol 12:963–978PubMed Butters N, Grant I, Haxby J, Judd LL, Martin A, McClelland J, Pequegnat W, Schacter D, Stover E (1990) Assessment of AIDS-related cognitive changes: recommendations of the NIMH workshop on neuropsychological assessment approaches. J Clin Exp Neuropsychol 12:963–978PubMed
11.
go back to reference White DA, Heaton RK, Monsch AU (1995) Neuropsychological studies of asymptomatic human immunodeficiency virus-type-1 infected individuals. The HNRC group. HIV Neurobehavioral Research Center. J Int Neuropsychol Soc 1:304–315PubMedCrossRef White DA, Heaton RK, Monsch AU (1995) Neuropsychological studies of asymptomatic human immunodeficiency virus-type-1 infected individuals. The HNRC group. HIV Neurobehavioral Research Center. J Int Neuropsychol Soc 1:304–315PubMedCrossRef
12.
go back to reference Faust D, Fogel BS (1989) The development and initial validation of a sensitive bedside cognitive screening test. J Nerv Ment Dis 177:25–31CrossRefPubMed Faust D, Fogel BS (1989) The development and initial validation of a sensitive bedside cognitive screening test. J Nerv Ment Dis 177:25–31CrossRefPubMed
14.
go back to reference Collie A, Darby D, Maruff P (2001) Computerised cognitive assessment of athletes with sports related head injury. Br J Sports Med 35:297–302CrossRefPubMed Collie A, Darby D, Maruff P (2001) Computerised cognitive assessment of athletes with sports related head injury. Br J Sports Med 35:297–302CrossRefPubMed
15.
go back to reference Collie A, Maruff P, Darby DG, McStephen M (2003) The effects of practice on the cognitive test performance of neurologically normal individuals assessed at brief test–retest intervals. J Int Neuropsychol Soc 9:419–428CrossRefPubMed Collie A, Maruff P, Darby DG, McStephen M (2003) The effects of practice on the cognitive test performance of neurologically normal individuals assessed at brief test–retest intervals. J Int Neuropsychol Soc 9:419–428CrossRefPubMed
16.
go back to reference Makdissi M, Collie A, Maruff P, Darby DG, Bush A, McCrory P, Bennell K (2001) Computerised cognitive assessment of concussed Australian rules footballers. Br J Sports Med 35:354–360CrossRefPubMed Makdissi M, Collie A, Maruff P, Darby DG, Bush A, McCrory P, Bennell K (2001) Computerised cognitive assessment of concussed Australian rules footballers. Br J Sports Med 35:354–360CrossRefPubMed
17.
go back to reference Erlanger DM, Kaushik T, Broshek D, Freeman J, Feldman D, Festa J (2002) Development and validation of a web-based screening tool for monitoring cognitive status. J Head Trauma Rehabil 17:458–476PubMed Erlanger DM, Kaushik T, Broshek D, Freeman J, Feldman D, Festa J (2002) Development and validation of a web-based screening tool for monitoring cognitive status. J Head Trauma Rehabil 17:458–476PubMed
18.
go back to reference Erlanger D, Feldman D, Kutner K, Kaushik T, Kroger H, Festa J, Barth J, Freeman J, Broshek D (2003) Development and validation of a web-based neuropsychological test protocol for sports-related return-to-play decision-making. Arch Clin Neuropsychol 18:293–316CrossRefPubMed Erlanger D, Feldman D, Kutner K, Kaushik T, Kroger H, Festa J, Barth J, Freeman J, Broshek D (2003) Development and validation of a web-based neuropsychological test protocol for sports-related return-to-play decision-making. Arch Clin Neuropsychol 18:293–316CrossRefPubMed
19.
go back to reference Silbert BS, Maruff P, Evered LA, Scott DA, Kalpokas M, Martin KJ, Lewis MS, Myles PS (2004) Detection of cognitive decline after coronary surgery: a comparison of computerized and conventional tests. Br J Anaesth 92:814–820CrossRefPubMed Silbert BS, Maruff P, Evered LA, Scott DA, Kalpokas M, Martin KJ, Lewis MS, Myles PS (2004) Detection of cognitive decline after coronary surgery: a comparison of computerized and conventional tests. Br J Anaesth 92:814–820CrossRefPubMed
20.
go back to reference Miller EN, Wilkie FL (1994) Computerized testing to assess cognition in HIV-positive individuals. In: Grant I, Martin A (eds) Neuropsychology of HIV infection. Oxford Univ. Press, New York, pp 161–175 Miller EN, Wilkie FL (1994) Computerized testing to assess cognition in HIV-positive individuals. In: Grant I, Martin A (eds) Neuropsychology of HIV infection. Oxford Univ. Press, New York, pp 161–175
21.
go back to reference Gonzalez R, Heaton RK, Moore DJ, Letendre S, Ellis RJ, Wolfson T, Marcotte T, Cherner M, Rippeth J, Grant I (2003) Computerized reaction time battery versus a traditional neuropsychological battery: detecting HIV-related impairments. J Int Neuropsychol Soc 9:64–71CrossRefPubMed Gonzalez R, Heaton RK, Moore DJ, Letendre S, Ellis RJ, Wolfson T, Marcotte T, Cherner M, Rippeth J, Grant I (2003) Computerized reaction time battery versus a traditional neuropsychological battery: detecting HIV-related impairments. J Int Neuropsychol Soc 9:64–71CrossRefPubMed
22.
go back to reference Collie A, Maruff P, Makdissi M, McCrory P, McStephen M, Darby D (2003) CogSport: reliability and correlation with conventional cognitive tests used in postconcussion medical evaluations. Clin J Sport Med 13:28–32CrossRefPubMed Collie A, Maruff P, Makdissi M, McCrory P, McStephen M, Darby D (2003) CogSport: reliability and correlation with conventional cognitive tests used in postconcussion medical evaluations. Clin J Sport Med 13:28–32CrossRefPubMed
23.
go back to reference Erlanger D, Kaushik T, Cantu R, Barth JT, Broshek DK, Freeman JR, Webbe FM (2003) Symptom-based assessment of the severity of a concussion. J Neurosurg 98:477–784PubMedCrossRef Erlanger D, Kaushik T, Cantu R, Barth JT, Broshek DK, Freeman JR, Webbe FM (2003) Symptom-based assessment of the severity of a concussion. J Neurosurg 98:477–784PubMedCrossRef
24.
go back to reference Cella DF, Tulsky DS, Gray G, Sarafian B, Linn E, Bonomi A, Silberman M, Yellen SB, Winicour P, Brannon J et al (1993) The functional assessment of cancer therapy scale: development and validation of the general measure. J Clin Oncol 11:570–579PubMed Cella DF, Tulsky DS, Gray G, Sarafian B, Linn E, Bonomi A, Silberman M, Yellen SB, Winicour P, Brannon J et al (1993) The functional assessment of cancer therapy scale: development and validation of the general measure. J Clin Oncol 11:570–579PubMed
25.
go back to reference Wagner LI, SJ, Cella D, Donninger N (2003) Chemotherapy-related cognitive deficits: A qualitative examination of patients and providers. Ann Behav Med 25:S056 Wagner LI, SJ, Cella D, Donninger N (2003) Chemotherapy-related cognitive deficits: A qualitative examination of patients and providers. Ann Behav Med 25:S056
26.
go back to reference Fan H, Houédé-Tchen N, Yi Q-L, Chemerynsky I, Downie FP, Sabate K, Tannock IF (2005) Fatigue, menopausal symptoms and cognitive function in women following adjuvant chemotherapy for breast cancer: one and two year follow-up of a prospective controlled study. J Clin Oncol 23:8025–8032CrossRefPubMed Fan H, Houédé-Tchen N, Yi Q-L, Chemerynsky I, Downie FP, Sabate K, Tannock IF (2005) Fatigue, menopausal symptoms and cognitive function in women following adjuvant chemotherapy for breast cancer: one and two year follow-up of a prospective controlled study. J Clin Oncol 23:8025–8032CrossRefPubMed
27.
go back to reference Falleti MG, Maruff P, Collie A, Darby DG (2006) Practice effects associated with the repeated assessment of cognitive function using the CogState battery at 10-minute, one week and one month test–retest intervals. J Clin Exp Neuropsychol (in press) Falleti MG, Maruff P, Collie A, Darby DG (2006) Practice effects associated with the repeated assessment of cognitive function using the CogState battery at 10-minute, one week and one month test–retest intervals. J Clin Exp Neuropsychol (in press)
28.
go back to reference Symes E, Maruff P, Ajani A, Currie J (2000) Issues associated with the identification of cognitive change following coronary artery bypass grafting. Aust N Z J Psychiatry 34:770–784CrossRefPubMed Symes E, Maruff P, Ajani A, Currie J (2000) Issues associated with the identification of cognitive change following coronary artery bypass grafting. Aust N Z J Psychiatry 34:770–784CrossRefPubMed
29.
go back to reference Borowicz LM, Goldsborough MA, Selnes OA, McKhann GM (1996) Neuropsychologic change after cardiac surgery: a critical review. J Cardiothorac Vasc Anesth 10:105–111CrossRefPubMed Borowicz LM, Goldsborough MA, Selnes OA, McKhann GM (1996) Neuropsychologic change after cardiac surgery: a critical review. J Cardiothorac Vasc Anesth 10:105–111CrossRefPubMed
30.
go back to reference Woods SP, Weinborn M, Lovejoy DW (2003) Are classification accuracy statistics underused in neuropsychological research? J Clin Exp Neuropsychol 25:431–439PubMed Woods SP, Weinborn M, Lovejoy DW (2003) Are classification accuracy statistics underused in neuropsychological research? J Clin Exp Neuropsychol 25:431–439PubMed
31.
go back to reference Taylor MJ, Heaton RK (2001) Sensitivity and specificity of WAIS-III/WMS-III demographically corrected factor scores in neuropsychological assessment. J Int Neuropsychol Soc 7:867–874CrossRefPubMed Taylor MJ, Heaton RK (2001) Sensitivity and specificity of WAIS-III/WMS-III demographically corrected factor scores in neuropsychological assessment. J Int Neuropsychol Soc 7:867–874CrossRefPubMed
32.
go back to reference Benedict RH, Zgaljardic DJ (1998) Practice effects during repeated administrations of memory tests with and without alternate forms. J Clin Exp Neuropsychol 20:339–352PubMedCrossRef Benedict RH, Zgaljardic DJ (1998) Practice effects during repeated administrations of memory tests with and without alternate forms. J Clin Exp Neuropsychol 20:339–352PubMedCrossRef
33.
go back to reference Collie A, Maruff P, Makdissi M, McStephen M, Darby DG, McCrory P (2004) Statistical procedures for determining the extent of cognitive change following concussion. Br J Sports Med 38:273–278CrossRefPubMed Collie A, Maruff P, Makdissi M, McStephen M, Darby DG, McCrory P (2004) Statistical procedures for determining the extent of cognitive change following concussion. Br J Sports Med 38:273–278CrossRefPubMed
34.
go back to reference McCaffrey RJ, Cousins JP, Westervelt HJ, Martynowicz M, Remick SC, Szebenyi S, Wagle WA, Bottomley PA, Hardy CJ, Haase RF (1995) Practice effects with the NIMH AIDS abbreviated neuropsychological battery. Arch Clin Neuropsychol 10:241–250CrossRefPubMed McCaffrey RJ, Cousins JP, Westervelt HJ, Martynowicz M, Remick SC, Szebenyi S, Wagle WA, Bottomley PA, Hardy CJ, Haase RF (1995) Practice effects with the NIMH AIDS abbreviated neuropsychological battery. Arch Clin Neuropsychol 10:241–250CrossRefPubMed
Metadata
Title
Assessing cognitive function in cancer patients
Authors
Janette Vardy
Karen Wong
Qi-long Yi
Alison Park
Paul Maruff
Lynne Wagner
Ian F. Tannock
Publication date
01-11-2006
Publisher
Springer-Verlag
Published in
Supportive Care in Cancer / Issue 11/2006
Print ISSN: 0941-4355
Electronic ISSN: 1433-7339
DOI
https://doi.org/10.1007/s00520-006-0037-6

Other articles of this Issue 11/2006

Supportive Care in Cancer 11/2006 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine